Skip to main content

IMPACTO DE LA INFECCION RESPIRATORIA VIRAL SOBRE EL MICROBIOMA DE EJE INTESTINO-PULMON EN LA FIBROSIS QUISTICA

PI18/00934

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2018
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARC TAULI
Execution centre CORPORACION SANITARIA PARC TAULI

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Respiratory Microbiome in Cystic Fibrosis, Compartment Patterns and Clinical Relationships in Early Stage Disease

  • Garcia-Nuñez, Marian|||0000-0002-5158-3758
  • Garcia-Gonzalez, Miguel
  • Pomares, Xavier|||0000-0002-2783-414X
  • Montón, Concepción
  • Millares, Laura|||0000-0002-0242-0274
  • Quero, Sara|||0000-0002-6454-6358
  • Prina, Elena
  • Asensio-De la Cruz, Oscar|||0000-0001-9304-3074
  • Bosque, Montserrat|||0000-0001-5426-4034
  • Capilla, Silvia|||0000-0002-7274-2973
  • Cuevas, Oscar|||0000-0001-7999-7701
  • Monsó, Eduard
We compared the bacterial microbiomes lodged in the bronchial tree, oropharynx and nose of patients with early stage cystic fibrosis (CF) not using chronic antibiotics, determining their relationships with lung function and exacerbation frequency. CF patients were enrolled in a cohort study during stability and were checked regularly over the following 9 months. Upper respiratory samples (sputum [S], oropharyngeal swab [OP] and nasal washing [N]) were collected at the first visit and every 3 months. 16S rRNA gene amplification and sequencing was performed and analyzed with QIIME. Seventeen CF patients were enrolled (16.6 SD 9.6 years). Alpha-diversity of bacterial communities between samples was significantly higher in S than in OP (Shannon index median 4.6 [IQR: 4.1-4.9] vs. 3.7 [IQR: 3-1-4.1], p = 0.003/Chao 1 richness estimator median 97.75 [IQR: 85.1-110.9] vs. 43.9 [IQR: 31.7-59.9], p = 0.003) and beta-diversity analysis also showed significant differences in the microbial composition of both respiratory compartments (Adonis test of Bray Curtis dissimilarity matrix, p = 0.001). Dominant taxa were found at baseline in five patients (29.4%), who showed lower forced expiratory volume in the first second (FEV1%, mean 74.8 [SD 19] vs. 97.2 [SD 17.8], p = 0.035, Student t test). The Staphylococcus genus had low RAs in most samples (median 0.26% [IQR 0.01-0.69%]), but patients with RA
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

The Microbiome in COPD, Emerging Potential for Microbiome-Targeted Interventions

  • Millares, Laura|||0000-0002-0242-0274
  • Monso, Eduard|||0000-0003-1876-3092
The aim of interventions over the respiratory microbiome in COPD is to preserve the original microbial flora, focusing in taxa with a demonstrated impact on the prognosis of the disease. Inhaled therapy is the main treatment for COPD, and chronic corticosteroid use is recommended for patients with frequent exacerbations. This therapy, however, increases both the bronchial microbial load and the abundance of potentially pathogenic bacteria in patients with low peripheral eosinophil counts, and to minimize its use in patients without peripheral eosinophilia, when possible, may avoid increases in bacterial loads of microorganisms as Haemophilus influenzae and Streptococcus pneumoniae. In exacerbations antibiotics determine a decrease in the microbial diversity, a change that persists during stability periods in frequent exacerbators. High-diversity bronchial microbiomes are enriched in non-dominant genera and determine low exacerbation frequencies and survival improvement. Limiting the antibiotic use to the treatment of exacerbations which would clearly benefit would favor the diversity of the respiratory microbiome and may have a positive impact on quality of life and survival. Oral antiseptics have shown and effect on the bronchial microbiome that was associated with improvements in quality of life, and the gut microbiome may be also modified through the oral administration of probiotics or prebiotics, that potentially may determine decreases in lung inflammation and bronchial hyperreactivity. High fiber diets also favor the production of anti-inflammatory molecules by the digestive flora, which would reach the respiratory system through the bloodstream. Interventional approaches favoring the preservation of the respiratory microbiome in COPD need first to select accurately the patients who would benefit from long-term inhaled corticosteroids and antibiotic treatments during exacerbations, under the hypothesis that keeping a respiratory microbiome close to the healthy subject would favor the respiratory health. Additionally, high fiber diets may be able to modify the gut microbiome and influence the respiratory system through the gut-lung axis. Therapeutic approaches targeting the microbiome to improve COPD, however, still require clinical validation and the identification of patient subtypes who would benefit the most with their use.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Relationship between Respiratory Microbiome and Systemic Inflammatory Markers in COPD, A Pilot Study

  • Casadevall, Carme|||0000-0001-6458-8972
  • Quero, Sara|||0000-0002-6454-6358
  • Millares, Laura|||0000-0002-0242-0274
  • Faner, Rosa|||0000-0002-8159-0115
  • Cosio, Borja G.|||0000-0002-6388-8209
  • Peces-Barba, Germán
  • Castro Acosta, Ady|||0000-0001-7591-6011
  • Montón, Concepción
  • Palou, Alexandre
  • Pascual-Guardia, Sergi|||0000-0002-6567-0916
  • Agustí, Àlvar
  • Gea Guiral, Joaquim|||0000-0001-8718-7346
  • Monso, Eduard|||0000-0003-1876-3092
The respiratory microbiome may influence the development and progression of COPD by modulating local immune and inflammatory events. We aimed to investigate whether relative changes in respiratory bacterial abundance are also associated with systemic inflammation, and explore their relationship with the main clinical COPD phenotypes. Multiplex analysis of inflammatory markers and transcript eosinophil-related markers were analyzed on peripheral blood in a cohort of stable COPD patients (n = 72). Respiratory microbiome composition was analyzed by 16S rRNA microbial sequencing on spontaneous sputum. Spearman correlations were applied to test the relationship between the microbiome composition and systemic inflammation. The concentration of the plasma IL-8 showed an inverted correlation with the relative abundance of 17 bacterial genera in the whole COPD cohort. COPD patients categorized as eosinophilic showed positive relationships with blood eosinophil markers and inversely correlated with the degree of airway obstruction and the number of exacerbations during the previous year. COPD patients categorized as frequent exacerbators were enriched with the bacterial genera Pseudomonas which, in turn, was positively associated with the severity of airflow limitation and the prior year's exacerbation history. The associative relationships of the sputum microbiome with the severity of the disease emphasize the relevance of the interaction between the respiratory microbiota and systemic inflammation.